Evidence map›Paper›PMID 32879137›Full record

ArticleJCI insight2020

Epigenetic regulation of the PGE2 pathway modulates macrophage phenotype in normal and pathologic wound repair.

Frank M Davis, Lam C Tsoi, Rachael Wasikowski, Aaron denDekker, Amrita Joshi, Carol Wilke, Hongping Deng, Sonya Wolf, Andrea Obi, Steven Huang and 11 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Macrophage HM13/SPP Enhances Foamy Macrophage Formation and Atherogenesis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Prostaglandin EEXCLI journal · 2025
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 2 countries.

Frank M DavisSection of Vascular Surgery, Department of Surgery.
Lam C TsoiDepartment of Dermatology, and.
Rachael WasikowskiDepartment of Dermatology, and.
Aaron denDekkerSection of Vascular Surgery, Department of Surgery.
Amrita JoshiSection of Vascular Surgery, Department of Surgery.
Carol WilkeDepartment of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Hongping DengDepartment of Bioengineering, University of Illinois, Champaign, Illinois, USA.
Sonya WolfSection of Vascular Surgery, Department of Surgery.
Andrea ObiSection of Vascular Surgery, Department of Surgery.
Steven HuangDepartment of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Allison C BilliDepartment of Dermatology, and.
Scott RobinsonSection of Vascular Surgery, Department of Surgery.
Jay LipinskiSection of Vascular Surgery, Department of Surgery.
William J MelvinSection of Vascular Surgery, Department of Surgery.
Christopher O AuduSection of Vascular Surgery, Department of Surgery.
Stephan WeidingerDepartment of Dermatology, Venereology and Allergy, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Steven L KunkelDepartment of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Andrew SmithDepartment of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Johann E GudjonssonDepartment of Dermatology, and.
Bethany B MooreDepartment of Microbiology and Immunology.
Katherine A GallagherSection of Vascular Surgery, Department of Surgery.
Center for Vascular Biology Research · USUniversity of Michigan · USUniversity Hospital Schleswig-Holstein · DEUniversity of Illinois Urbana-Champaign · US

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Strategic Vision & Impact on Environmental HealthP30ES017885 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Dana Dolinoy · 2011 to 2026
$21.3M
University of Michigan Skin Biology and Diseases Resource-based CenterP30AR075043 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANDRZEJ A. DLUGOSZ · 2019 to 2026
$6.6M
NIDDK Diabetic Foot Consortium Clinical Research UnitU01DK119083 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RODICA BUSUI (POP-BUSUI), Crystal Murray Holmes · 2018 to 2026
$5.5M
Immunobiology of Lung Injury and FibrosisR35HL144481 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MOORE, BETHANY B. · 2019 to 2024
$5.2M
TRAINING PROGRAM IN CELL AND MOLECULAR DERMATOLOGYT32AR007197 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JAMES TILFORD ELDER, Sunny Y Wong · 1986 to 2026
$4.2M
The Interferon-beta (IFN-beta)/SETDB2 Epigenetic Axis Regulates Inflammation And Metabolism In Diabetic WoundsR01HL137919 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GALLAGHER, KATHERINE ANN · 2017 to 2021
$2.4M
miR-29b and autophagy regulate alveolar macrophage function post-BMTR01AI117229 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MOORE, BETHANY B. · 2015 to 2019
$2.2M
Role of IL-13 and the IL-13 Associated rs20541 Risk Variant in the Pathogenesis of PsoriasisR01AR069071 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GUDJONSSON, JOHANN ELI · 2015 to 2019
$2.1M
Targeted Drug Delivery to Adipose Tissue Macrophages in ObesityR01DK112251 · NIDDK · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI SMITH, ANDREW MICHAEL, SWANSON, KELLY S · 2016 to 2020
$2.1M
Epigenetic Regulation of Prostaglandin E2 (PGE2) Synthesis Alters Macrophage Function to Promote Inflammation and Impair Diabetic Wound HealingR01DK124290 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GALLAGHER, KATHERINE ANN, MOORE, BETHANY B. · 2020 to 2023
$1.8M
Epigenetic Changes in Bone Marrow Progenitor Cells Impair Diabetic Wound HealingK08DK102357 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GALLAGHER, KATHERINE ANN · 2013 to 2017
$782k
NHLBI NIH HHS R01 HL137919NHLBI NIH HHS R35 HL144481NIAID NIH HHS R01 AI117229NIAMS NIH HHS K01 AR072129NIAMS NIH HHS P30 AR075043NIAMS NIH HHS R01 AR069071NIAMS NIH HHS T32 AR007197NIDDK NIH HHS F32 DK117545NIDDK NIH HHS K08 DK102357NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK112251NIDDK NIH HHS R01 DK124290NIDDK NIH HHS U01 DK119083NIEHS NIH HHS P30 ES017885
6 · The paper itself

Abstract

Macrophages are a primary immune cell involved in inflammation, and their cell plasticity allows for transition from an inflammatory to a reparative phenotype and is critical for normal tissue repair following injury. Evidence suggests that epigenetic alterations play a critical role in establishing macrophage phenotype and function during normal and pathologic wound repair. Here, we find in human and murine wound macrophages that cyclooxygenase 2/prostaglandin E2 (COX-2/PGE2) is elevated in diabetes and regulates downstream macrophage-mediated inflammation and host defense. Using single-cell RNA sequencing of human wound tissue, we identify increased NF-κB-mediated inflammation in diabetic wounds and show increased COX-2/PGE2 in diabetic macrophages. Further, we identify that COX-2/PGE2 production in wound macrophages requires epigenetic regulation of 2 key enzymes in the cytosolic phospholipase A2/COX-2/PGE2 (cPLA2/COX-2/PGE2) pathway. We demonstrate that TGF-β-induced miRNA29b increases COX-2/PGE2 production via inhibition of DNA methyltransferase 3b-mediated hypermethylation of the Cox-2 promoter. Further, we find mixed-lineage leukemia 1 (MLL1) upregulates cPLA2 expression and drives COX-2/PGE2. Inhibition of the COX-2/PGE2 pathway genetically (Cox2fl/fl Lyz2Cre+) or with a macrophage-specific nanotherapy targeting COX-2 in tissue macrophages reverses the inflammatory macrophage phenotype and improves diabetic tissue repair. Our results indicate the epigenetically regulated PGE2 pathway controls wound macrophage function, and cell-targeted manipulation of this pathway is feasible to improve diabetic wound repair.

Indexed as

Epigenesis, GeneticWound HealingAgedAnimalsCyclooxygenase 2Diabetes MellitusDiabetes Mellitus, ExperimentalDinoprostoneGene Expression RegulationHumansInflammationMacrophagesMaleMiceMice, Inbred C57BLMice, KnockoutCyclooxygenase 2DinoprostoneNF-kappa BOxytocicsDiabetesEndocrinologyEpigeneticsInflammationMacrophages

Identifiers

PMID32879137
PMCPMC7526451
OpenAlexW3082487870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.